2. Academic Validation
  3. Apoptotic neutrophil membrane-modified nanoparticles promote wound healing by enhancing efferocytotic capacity of dendritic cells

Apoptotic neutrophil membrane-modified nanoparticles promote wound healing by enhancing efferocytotic capacity of dendritic cells

  • J Control Release. 2025 Aug 13:386:114127. doi: 10.1016/j.jconrel.2025.114127.
Kai Ye 1,  Yan He 1,  Danfeng Jian 2,  Zhengtai Chen 1,  Hanxiao Sun 1,  Yufan Zhang 1,  Yuexue Mai 1,  Xinran Cao 3,  Jindan Wu 4,  Zhengwei Mao 5,  Chenggang Yi 6
Affiliations

Affiliations

  • 1 Department of Plastic Surgery, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou 310000, China.
  • 2 MOE Key Laboratory of Advanced Textile Materials & Manufacturing Technology, Zhejiang Sci-Tech University, Hangzhou 310018, China.
  • 3 MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China. Electronic address: 0623810@zju.edu.cn.
  • 4 MOE Key Laboratory of Advanced Textile Materials & Manufacturing Technology, Zhejiang Sci-Tech University, Hangzhou 310018, China. Electronic address: wujindan@zstu.edu.cn.
  • 5 MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China.
  • 6 Department of Plastic Surgery, The Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou 310000, China. Electronic address: yichg@zju.edu.cn.
PMID: 40816639 DOI: 10.1016/j.jconrel.2025.114127
Abstract

Chronic and large wound healing failures pose significant challenges in clinical practice. The major difficulty in wound healing concerns the limited efferocytic activity of dendritic cells (DCs). Focusing on the critical role of DCs efferocytosis in chronic wound healing, this study proposes a dual-pathway intervention strategy. Firstly, on the basis of the mechanism that SLC7A11 is abnormally highly expressed in diabetic wounds and inhibits the efferocytic activity of DCs, a novel inhibitor HG106 is utilized to target and inhibit SLC7A11, significantly enhancing the clearance efficiency of apoptotic cells by DCs. Secondly, inspired by the physiological apoptotic signals of neutrophils, an apoptotic neutrophil membrane (ANM)-modified Liposome (HG106-ANM@Lip) is constructed. This enhances the recognition and uptake of nanoparticles by DCs through the surface phosphatidylserine (PS) signal and synergistically activates the MERTK/Axl receptor pathway to initiate and enhance efferocytosis, improving the inflammatory microenvironment. In diabetic mice and a large wound model of Bama pigs, HG106-ANM@Lip demonstrates a good promoting effect on wound healing. In summary, this study presents an innovative synergistic strategy for chronic wound treatment, utilizing the dual mechanisms of molecular regulation and biomimetic delivery to reshape the inflammatory microenvironment.

Keywords

Apoptotic neutrophil membrane; Efferocytosis; Nanomedicine; SLCA711; Wound healing.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z